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ABSTRACT
Background: Healthcare professionals commonly exhibit negative attitudes 
toward people with mental disorders. Few international studies have sought to 
investigate the determinants of stigma. 
Objective: To conduct an international comparison of pharmacy students’ stigma 
towards people with schizophrenia, and to determine whether stigma is con-
sistently associated with stereotypical attributes of people with schizophrenia. 
Method: Students (n = 649) at eight universities in Australia, Belgium, India, Finland, 
Estonia and Latvia completed a seven-item Social Distance Scale (SDS) and 
six items related to stereotypical attributes of people with schizophrenia.
Results: Mean SDS scores were 19.65 (± 3.97) in Australia, 19.61 (± 2.92) in 
Belgium, 18.75 (± 3.57) in India, 18.05 (± 3.12) in Finland, and 20.90 (± 4.04) in 
Estonia and Latvia. Unpredictability was most strongly associated with having a 
high social distance in Australia (β = –1.285), the perception that people will never 
recover in India (β = –0.881), dangerousness in Finland (β = –1.473) and the per-
ception of being diffi cult to talk to in Estonia and Latvia (β = –2.076). Unpredictability 
was associated with lower social distance in Belgium (β = 0.839).
Conclusion: The extent to which students held stigmatizing attitudes was 
similar in each country, however, the determinants of stigma were different. 
Pharmacy education may need to be tailored to address the determinants of 
stigma in each country.
Key words: schizophrenia, social distance, pharmaceutical services
INTRODUCTION
The stigma attached to mental disorders is an increasingly researched topic that is relevant to 
help-seeking by consumers, provision of healthcare services, development of education curricula 
and policy development (Angermeyer et al., 2003; Angermeyer et al., 2004a; Angermeyer & 
Dietrich, 2006; Griffi ths et al., 2006; Lee, 2002; Sartorius, 2007; van ‘t Veer et al., 2006). Stigma 
has been defi ned as a negative attitude, based on prejudice and misinformation, that is triggered 
International Journal of Social Psychiatry. © The Author(s), 2010. Reprints and permissions: 
http://www.sagepub.co.uk/journalsPermissions.nav Vol 56(1): 3–14 DOI: 10.1177/0020764008097621
4 INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY 56(1)
by a marker of an illness (Sartorius, 2007). The World Health Organization has described stigma 
as the greatest impediment to the provision of effective mental healthcare in the community 
setting (WHO, 2001).
Attitudes of healthcare professionals 
Healthcare professionals often have sub-optimal attitudes toward people with mental disorders 
(Buchanan & Bhugra, 1992; Lauber et al., 2006; Nordt et al., 2006). Given the shift towards pro-
viding care in the community, the attitudes and competencies of primary healthcare professionals, 
including pharmacists, have attracted recent attention (Bell et al., 2006a; Cates et al., 2005; Phokeo 
et al., 2004; Wilson et al., 2007; Volmer et al., 2008). Pharmacists are among the most accessible 
and frequently consulted health professionals within their communities (Jesson & Bissell, 2006). 
New pharmaceutical care services provided by community pharmacists are potentially well suited 
to optimizing the use of medications for mental disorders (Bell et al., 2005). However, pharmacists 
have reported feeling less confi dent conducting medication counselling, and may provide less 
drug information, for people with mental disorders than for those with cardiovascular disease, 
diabetes or asthma (Maslen et al., 1996; Phokeo et al., 2004; Vainio et al., 2002). Undergraduate 
pharmacy education is changing to refl ect the new pharmaceutical care roles performed by 
pharmacists (Bell et al., 2006b; Bell et al., 2006c). In the USA all schools of pharmacy now 
include psychiatric topics as part of a therapeutics-based course, and over 75% employ a specialist 
psychiatric pharmacist (Cates et al., 2007). However, few previous studies have investigated the 
determinants of sub-optimal attitudes toward people with mental disorders among pharmacy 
students (Volmer et al., 2008).
Mental health stigma
Social distance from people with schizophrenia is a commonly used indicator of mental health 
stigma. Social distance has been defi ned as the willingness to engage in relationships of varying 
intimacy with a person (Lauber et al., 2004). The stereotypes of people with mental disorders as 
being unpredictable, dangerous, untrustworthy, aggressive, having a poor prognosis and causing 
disturbance have been associated with a large social distance (Angermeyer et al., 2003; Grausgruber 
et al., 2007; van ‘t Veer et al., 2006). If adopted, these stereotypes may lead to prejudice and dis-
crimination (Corrigan & Watson, 2002). According to the attribution model, believing the causes 
of a mental disorder to be due to factors beyond an individual’s control, such as genetic factors, 
is associated with low social distance (Angermeyer et al., 2003; Corrigan et al., 2000; Corrigan 
et al., 2003). A conceptual model linking familiarity with mental disorders to low social distance 
has also been proposed (Corrigan et al., 2001). This model has been replicated using data from 
a representative population survey in Germany (Angermeyer et al., 2004b) and has been utilized 
to improve pharmacy students’ attitudes toward people with mental disorders in Australia (Bell 
et al., 2006b).
Culture may impact the way people with mental disorders seek and receive mental healthcare. 
The determinants of stigma may be culturally specifi c (Angermeyer & Dietrich, 2006; Kleinman, 
2004). Understanding the cultural determinants of stigma is important so that education curricula 
and public-health campaigns can be customized accordingly (Angermeyer et al., 2004a; Lauber 
et al., 2004). There are cultural differences in the way that people experience mental disorders 
in Asian and Western societies (Griffi ths et al., 2006; Tsang et al., 2007). Mental health stigma in 
India may be linked to specifi c beliefs about the causes of mental disorders (Charles et al., 2007). 
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However, there are no established or widely accepted theoretical frameworks for assessing the 
cultural basis of stigma (Lee, 2002). No previous studies have examined the possible impact of 
culture or the country in which students study on the determinants of mental health stigma 
among pharmacy students.
Study objectives 
The objectives of this study were: (1) to compare and contrast pharmacy students’ social distance 
from people with schizophrenia in Australia, Belgium, Finland, India, Estonia and Latvia; and 
(2) to determine whether social distance is consistently associated with stereotypical attributes 
of people with schizophrenia.
METHODS
Participants
Data for this study were collected from third-year pharmacy students studying at eight universities 
in Australia, Belgium, Finland, India, Estonia and Latvia. Third-year students were selected as the 
target population because this is the fi nal year of study for those students undertaking a Bachelor’s 
of Pharmacy degree which is consistent with the structure outlined in the Bologna Declaration, 
an agreement to create a common framework for higher education across Europe (Confederation 
of EU Rectors’ Conferences & Association of European Universities, 2000). All universities that 
participated in our study provided education related to schizophrenia and antipsychotic drugs, 
however, the format and duration of this education varied between universities.
The study was approved by the Human Research Ethics Committee at the University of Sydney 
and the Institutional Review Board at Riga Stradins University. All study procedures were con-
ducted in accordance with the World Medical Association Declaration of Helsinki (World Medical 
Association, 2004).
Data collection
Data for this study were collected as part of the International Pharmacy Students’ Health Survey 
(IPSHS) (Bell et al., 2008). This census survey of 55-items aimed to assess respondents’ attitudes 
and willingness to provide pharmaceutical care to people with mental disorders. All third-year 
pharmacy students at the participating universities were invited to voluntarily complete the survey 
instrument during a lecture or tutorial. The survey instrument was administered in English or in 
an offi cial language of the respective country. All data were collected over the period February 
2006 to May 2007.
Survey instrument
The survey instrument included the seven-item Social Distance Scale (SDS) (Link et al., 1987), 
as well as six items related to common stereotypical beliefs about people with schizophrenia. 
The SDS has established validity and reliability, and requires respondents to indicate their 
willingness to engage into relationships of varying intimacy with a person previously hospitalized 
with schizophrenia (Corrigan et al., 2001; Link et al., 1987). The SDS was selected as a measure 
of mental health stigma because social distance has been used as an indicator of stigma in a 
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wide range of countries, cultures and study populations (Angermeyer et al., 2003). The SDS was 
scored on four-point Likert scales, ranging from 1 (defi nitely willing) to 4 (defi nitely unwilling). 
Possible total SDS scores ranged from 7 to 28, with lower scores indicative of less social distance. 
The six stereotypical beliefs about schizophrenia that were included in the analyses were based on 
a review of stigma and mental health (Hayward & Bright, 1997), and surveys conducted in the UK 
(Crisp et al., 2000; Mukherjee et al., 2002). The beliefs were ‘danger to others’, ‘unpredictable’, 
‘diffi cult to talk to’, ‘will never recover’, ‘have themselves to blame’ and ‘will not improve without 
treatment’. Respondents were asked to indicate how strongly they endorsed each of the above 
stereotypes using fi ve-point Likert scales ranging from 1 (strongly agree) to 5 (strongly disagree). 
The percentage of students who agreed or strongly agreed with each of the stereotypical beliefs 
has been reported previously (Bell et al., 2008).
The English version of the survey instrument was used in Australia, Belgium, India and Latvia. 
The instrument was translated into Finnish for use in Finland and Estonian for use in Estonia. 
The translations were performed using a predefi ned protocol adapted from a procedure used by 
previous researchers (Angermeyer et al., 2005). Two translators independently translated the 
original English version of the survey instrument into the target language. These translators then 
met to compare and resolve any differences in their translations. Their translation was then back-
translated by a third translator, before a bilingual panel was formulated to compare the original and 
translated versions. Differences were discussed and some sentences reformulated until equivalence 
was achieved. The translated Finnish and Estonian versions of the survey instrument were pilot 
tested for face-validity prior to use.
Data analysis
Data were analysed using the Statistical Package for the Social Sciences version 14.0 (Chicago, IL). 
Demographic information was coded and tabulated. Frequencies for each item of the questionnaire 
were computed and tabulated. Due to the low number of students studying pharmacy in Estonia and 
Latvia, data from these two neighbouring Baltic countries were pooled. The total SDS scale score 
was calculated by summing the individual responses for each item. Cronbach’s α was calculated 
to determine the internal consistency of the SDS at each study location. Standard linear regression 
analyses were performed for each country using the total SDS score as the dependent variable. The 
six stereotypical beliefs, as well as age, gender and family experience of mental disorder, were used 
as independent variables in all linear regression analyses. Cases with missing data were excluded 
from the linear regression analyses. The correlation matrix and squared multiple correlations 
were computed to test for multicollinearity. The level of signifi cance was set at 0.05. To account 
for the possibility of Type I error caused by multiple signifi cance testing, p values from the 
linear regression analyses were adjusted using the Holm Method (Aickin & Gensler, 1996).
RESULTS
Completed survey instruments were returned by students from Australia (n = 241, 98% response 
rate), Belgium (n = 102, 74% response rate), India (n = 106, 91% response rate), Finland 
(n = 130, 81% response rate), and Estonia and Latvia (n = 70, 86% response rate). The average 
age of respondents ranged from 20.0 years in India to 25.5 years in Finland (Table 1). The gender 
distribution ranged from 57.5% female respondents in India to 90.0% female respondents in 
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Finland. Fifty-two per cent of students studying in Australia were born in Australia, whereas over 
90% of students studying at other universities were born in the country in which they studied. 
Students’ desire for social distance was highest in Estonia and Latvia 20.90 (± 4.04) and lowest 
in Finland 18.05 (± 3.12) (Table 2). The range of the mean social distance scores was 2.85. The 
Cronbach’s α value for the SDS was 0.87 in Australia, 0.78 in Belgium, 0.71 in India, 0.83 in 
Finland, and 0.93 in Estonia and Latvia. 
Unpredictability was most strongly associated with having a high social distance in Australia 
(β = –1.285), the perception that people will never recover in India (β = –0.881), dangerousness in 
Finland (β = –1.473) and the perception of being diffi cult to talk to in Estonia and Latvia (β = –2.076) 
(Table 3). Unpredictability was associated with lower social distance in Belgium (β = 0.839). After 
adjusting the p values using the Holm Method, only unpredictability in Australia (p < 0.009), 
danger in Helsinki (p < 0.009) and being diffi cult to talk to in Estonia and Latvia (p = 0.027) 
remained statistically signifi cant determinants of social distance.
DISCUSSION
The results of our study indicate that social distance may be associated with different stereotypical 
beliefs about people with schizophrenia in different countries. While a previous review concluded 
that unpredictability is most strongly associated with social distance (Angermeyer et al., 2003), 
this was not true among all respondents in our study. Unpredictability was most strongly associated 
with social distance among students studying in Australia, a fi nding that has also been reported 
among members of the German general public (Angermeyer et al., 2004a). However, in Belgium 
unpredictability was associated with desire for less social distance. This fi nding runs counter to 
most other empirical evidence (Angermeyer & Dietrich, 2006), but is consistent with results of 
a recent Estonian pharmacy student survey (Volmer et al., 2008). Further research is needed to 
determine whether these counter-intuitive fi ndings are replicated in other studies and groups of 
pharmacy students. Dangerousness was most strongly associated with social distance in Finland. 
The perception that people with schizophrenia will never recover was more closely associated 
with social distance than either unpredictability or dangerousness in India. Our results support the 
notion that stereotypical beliefs associated with social distance may differ by country and cultural 
group, a fi nding previously reported from a study conducted in Germany, Mongolia and Russia 
(Angermeyer et al., 2004a).
The students’ desire for social distance was similar in all countries in which the survey was 
conducted. The range of mean social distance scores between countries was comparable to the 
improvement of 1.91 in total social distance score observed after a short-term consumer-led 
education programme in Sydney (Bell et al., 2006b). While there were small yet statistically 
signifi cant differences in social distance between countries in our study, further research is needed 
to determine the importance of these differences in practice. Previous research has suggested 
that social distance is less in Africa and Asia than in ‘Western’ countries, although this fi nding 
has been challenged (Adewuya & Makanjuola, 2005). Our results lend weight to these fi ndings, 
with mean social distance in India being less than in Australia, Belgium, Estonia or Latvia.
The fact that the regression models only explained between 12% and 24% of variance in social 
distance suggests that common stereotypical beliefs about people with schizophrenia may have 
a limited role in predicting social distance. The stereotypical attitudes presented in the study 
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explained only 12% of the variance in social distance in India, compared to more than 18% at 
other study locations. This suggests that social distance may be associated with a range of different 
beliefs in India. This fi nding is consistent with the notion that people with mental disorders in 
developing countries may be less likely than those in developed countries to face exclusion due to 
loss of self-esteem, status and independence (Littlewood, 1998). The fact that the regression models 
explained less than 24% of variance cautions against over-emphasizing the role of stereotypical 
beliefs as determinants of social distance. Further research is needed to examine the impact of 
culture using alternative scales and constructs.
Demographic characteristics explained only a small amount of the variance in desire for social 
distance in our study. Previous research has demonstrated inconsistent results with respect to 
gender and social distance (Angermeyer & Dietrich, 2006). While several previous studies have 
reported a higher social distance among females than males (Gaebel et al., 2002; Lauber et al., 
2004; Adewuya & Makanjuola, 2005), female gender was not a determinant of social distance at 
any of our study locations. Additionally, and contrary to previous research (Angermeyer et al., 
2004b), familiarity with mental illness did not appear to be strongly associated with lower social 
distance scores in any participating country other than Australia. Despite evidence from previous 
research suggesting age is negatively associated with positive attitudes, this was not evident in our 
study (Angermeyer et al., 2004a). This may have been because the age range of the majority of 
students in our study was relatively small.
Pharmacy education and pharmacy practice in many countries remains predominantly focused 
on the pharmacological properties of medications rather than the needs and experiences of con-
sumers (de Oliveira & Shoemaker, 2006). Having a medical understanding of schizophrenia has 
been associated with greater social distance than perceiving schizophrenia as a life-crisis (Lauber 
et al., 2004). Paradoxically, increased knowledge about mental disorders corresponded to more 
negative attitudes in one study (Chou & Mak, 1998). Informing people about schizophrenia 
or depression may not be suffi cient to change their attitudes (Angermeyer & Dietrich, 2006). 
Traditional forms of pharmacy education, including lectures and tutorials led by pharmacists, may 
not improve students’ social distance from people with schizophrenia (Bell et al., 2006a). New 
models of pharmacy education involving greater participation by consumers may be useful to 
improve students’ attitudes (Bell et al., 2006b; Bell et al., 2006c).
Limitations 
As with several previous studies (Crisp et al., 2000; Mukherjee et al., 2002), the survey instru-
ment used in our study relied on students having a common understanding of schizophrenia. 
However, pharmacy curricula at all universities that participated in our study included lectures 
related to schizophrenia and antipsychotic drugs. Social distance is one indicator of mental health 
stigma, and the value of social distance as an indicator of stigma may vary between countries. 
Despite all data being collected anonymously, students may have under-reported family experi-
ence of mental illness. Students’ willingness to self-report family experience of mental illness may 
have also varied between countries.
Data were not collected from all universities offering pharmacy education in Australia, Belgium, 
Finland and India and, therefore, the respondents’ attitudes may not have been representative of all 
pharmacy students studying in these countries. Students studying pharmacy in Latvia and Estonia 
had different cultural backgrounds; however, data from these two neighbouring Baltic states 
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were pooled to perform the regression analyses. Future studies are needed to assess whether the 
determinants of social distance differ among students studying in Latvia and Estonia.
The Likert scales used in our study were ordinal scales; however, for the purpose of conducting 
the analyses all scales were treated as continuous variables. Further studies are needed to determine 
whether students’ stereotypical beliefs about people with schizophrenia or their desire for social 
distance impact their attitudes or behaviours in relation to providing pharmaceutical services. 
CONCLUSION
Social distance from people with schizophrenia was similar among students studying in Australia, 
Belgium, Estonia, Finland, India and Latvia. However, the stereotypical attributes associated with 
desire for social distance were different in each country. Pharmacy education may need to be 
tailored to address the determinants of stigma in each country. Models that seek to explain the deter-
minants of social distance are culturally specifi c.
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